M L Plunkett

Medicine · Health Sciences

14h-index1.6kcitations24works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(6), Angiogenesis and VEGF in Cancer(5), T-cell and B-cell Immunology(4), Glycosylation and Glycoproteins Research(4), Cell Adhesion Molecules Research(4)

Publications24 total

Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth
Clinical Cancer Research·2008· 91 citedOpen Access
Angiogenesis blockade as a new therapeutic approach to experimental colitis
Gut·2006· 126 citedOpen Access
A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis <i>in vivo</i>
Molecular Cancer Therapeutics·2006· 196 citedOpen Access
Integrins
Humana Press eBooks·2005
Peptides Derived from the Histidine-Proline Domain of the Histidine-Proline-Rich Glycoprotein Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities
Cancer Research·2004· 54 citedOpen Access
Regression of primary breast tumor and blockage of osteolytic skeletal metastasis by a non-RGD based integrin binding peptide (ATN-161) targeting α5β1 and αvβ3 in a xenograft model of breast cancer
Cancer Research·2004· 1 cited
Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
PubMed·2002· 89 cited
Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides
Canadian Journal of Physiology and Pharmacology·2002· 20 cited
Calcium alginate beads as a slow‐release system for delivering angiogenic molecules In Vivo and In Vitro
Journal of Cellular Physiology·1992· 146 cited
Epicardial and Corneal Mineralization in Clinically Normal Severe Combined Immunodeficiency (SCID) Mice
Veterinary Pathology·1992· 11 cited
A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis.
PubMed·1991· 25 cited
An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate.
PubMed·1990· 81 cited
Rosetting of human T lymphocytes with sheep and human erythrocytes. Comparison of human and sheep ligand binding using purified E receptor.
The Journal of Immunology·1987· 41 citedOpen Access
INTERACTION BETWEEN CD2 AND LFA-3 MEDIATES ROSETTING OF ACTIVATED HUMAN LYMPHOCYTES-T WITH HUMAN-E
1987
Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).
The Journal of Experimental Medicine·1987· 123 citedOpen Access
THE LYMPHOCYTE-T GLYCOPROTEIN CD2 (LFA-2/T11/E-ROSETTE RECEPTOR) BINDS THE CELL-SURFACE LIGAND LFA-3
FEDERATION PROCEEDINGS·1987· 14 cited
The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3
Nature·1987· 448 cited
Purification and characterization of the lymphocyte function-associated-2 (LFA-2) molecule.
The Journal of Immunology·1986· 35 citedOpen Access
Assignment of antigenic determinants to separated I-Ak kappa chains.
The Journal of Immunology·1983· 29 cited
Structures of the Oligosaccharides of I-Ak Antigen and Localization of Antigenic Sites to A α k and A β k Chains
Humana Press eBooks·1983
page 1 of 2Next →

Frequent Co-authors

Andrew P. Mazar(8), Fernando Doñate(7), Timothy A. Springer(6), Michael L. Dustin(5), David E. Shaw(5), J H Freed(5), Graham C. Parry(4), Martin E. Sanders(3), Ivy Beck(3), Shafaat A. Rabbani(3), Xiaojun Guan(3), Periasamy Selvaraj(2), Parisa Khalili(2), Nancy E. Robertson(2), Ziva Tel-Tsur(2), Jose C. Juarez(2), Natalya Shipulina(2), Jing-Chuan Zhang(2), Keith R. McCrae(2), William T. Morgan(2)